Interventional agents safety and pharmacokinetic services
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93025D00011
- Awardee
-
Eurofins Discovery Services North America, LLC UEI HF4LCAU68M93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $627,922 obligated
Award facts
- Combined order value
- $1,095,062 Current and potential, with all options
- Last date to order 16% complete
- IDV ceiling 1% used
- $50,000,000.00
- Maximum order
- $50,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 17 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to Eurofins Discovery Services North America, LLC on September 15, 2025, for interventional agents safety and pharmacokinetic services, with a ceiling of $50 million and ultimate completion date of September 14, 2032.
Work is performed at Eurofins' facilities in St. Charles, Missouri and other locations across the United States. The IDIQ procures advanced nonclinical research and development services supporting the development of interventional agents, encompassing safety evaluation, pharmacokinetic analysis, and associated preclinical testing methodologies aligned with Executive Order 14398.
The contract runs through September 2032 with a single base period and options structure. Since award, NIAID has issued at least one delivery order under this vehicle: a $1,095,062 firm-fixed-price order issued February 25, 2026, for interventional agents safety and pharmacokinetic services, performed in St. Charles, Missouri, with completion targeted for February 24, 2027.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Interventional agents safety and pharmacokinetic services | National Institute of Allergy and Infectious Diseases (NIH) | $627,922 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93025D00011?
75N93025D00011 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2025.
How much is contract 75N93025D00011 worth?
Orders under 75N93025D00011 have obligated $627,922. Their combined current value, with exercised options, is $1,095,062. 75N93025D00011's own ceiling is $50,000,000. A single order can be worth up to $50,000,000.
How many orders have been placed under contract 75N93025D00011?
1 order has been placed under 75N93025D00011, the latest on February 25, 2026.
Who can order from contract 75N93025D00011?
75N93025D00011 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93025D00011 competed?
The extent of competition for 75N93025D00011 was full and open competition. The government received 17 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV